Startups
Daiwa unit launches $135m fund to support drug discovery
DCI Partners targets Japan and Taiwan biotech startups developing COVID remedies
Biotechnology
China tech
China startup finds growth with $765 cancer-screening kit
Genetron rides COVID tailwind as health awareness rises and population ages
Food & Beverage
Singapore grants world's first approval to lab-grown meat
Chicken grown by US start-up Eat Just meets city-state's standards for use in nuggets
Pharmaceuticals
Celltrion spends $450m to ramp up contract drug production
South Korean pharma maker seeks to tap booming overseas demand
Food & Beverage
Is lab-grown steak coming to a grill near you?
Noodle maker Nissin aims to combat food shortages with cultured meat
Pharmaceuticals
Eisai to apply for Alzheimer's treatment approval in fiscal 2022
CEO Naito says trials go 'smoothly' and sees candidate as growth driver
Coronavirus
China's Sinovac starts production of COVID-19 vaccine candidate
Compatriot CanSino also rushes for mass output as clinical trials continue
Biotechnology
Fujifilm to make Novavax coronavirus vaccine component in UK
Production will fulfill order from British government for 60m doses
Pharmaceuticals
South Korea's Celltrion exports coronavirus tests to US
Diagnostic kits to help fill US testing gap
Biotechnology
Samsung Biologics to invest $1.5bn for new pharmaceutical plant
South Korean company predicts long-term growth in contract drugmaking business
Pharmaceuticals
AstraZeneca to supply Japan with 120m COVID-19 vaccine doses
Tokyo's second deal, after Pfizer agreement, diversifies early-stage supply
Biotechnology
Fujifilm to supply Novavax with key part of COVID vaccine
Japanese group ties up with US biotech company for late-stage trial
Coronavirus
AstraZeneca virus vaccine shows promise in trial
UK company expects to begin Japan tests in August
Coronavirus: Free to read
Coronavirus: Week of July 12 to July 18, Australian PM seeks to delay parliament
Singapore tightens rules on travelers from Japan, Hong Kong
DealStreetAsia
Singapore's Temasek expands investment in biotech companies
Sovereign fund leads UK Glympse Bio's $46.7m fundraising
SoftBank
Biotech IPO raises hopes for SoftBank Vision Fund rebound
Relay Therapeutics jumps 75% in Nasdaq debut
Coronavirus
Japan to pool $20bn with Europe, Canada for vaccine-buying fund
Smaller nations join forces to match US-China purchasing power
Biotechnology
China's Sinopharm doubles output capacity for 2020 vaccine launch
Drugmaker's two plants can produce 200m doses as candidate moves through trials
Markets
Glove makers and net stocks see COVID-19 boom in bear market
80% of Asia300 issues fell in first half of 2020, led by airlines and energy
Pharmaceuticals
Samsung Biologics snags $1.5bn in orders on pandemic rush
South Korean drug-making powerhouse sees stock price double this year